Go Pro
TSE:ACB

Aurora Cannabis (ACB) Stock Price, News & Analysis

Aurora Cannabis logo
C$5.03 +1.00 (+24.81%)
As of 08/11/2026 04:15 PM Eastern

About Aurora Cannabis Stock (TSE:ACB)

Advanced

Key Stats

Today's Range
C$4.55
C$5.14
50-Day Range
C$3.64
C$5.03
52-Week Range
C$3.59
C$9.33
Volume
2.13 million shs
Average Volume
412,633 shs
Market Capitalization
C$311.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$7.17
Consensus Rating
Moderate Buy

Company Overview

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Aurora Cannabis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

ACB MarketRank™: 

Aurora Cannabis scored higher than 57% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aurora Cannabis has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Aurora Cannabis has a consensus price target of C$7.17, representing about 42.5% upside from its current price of C$5.03.

  • Amount of Analyst Coverage

    Aurora Cannabis has only been the subject of 3 research reports in the past 90 days.

  • Read more about Aurora Cannabis' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aurora Cannabis is -2.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aurora Cannabis is -2.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aurora Cannabis has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ACB.
  • Dividend Yield

    Aurora Cannabis does not currently pay a dividend.

  • Dividend Growth

    Aurora Cannabis does not have a long track record of dividend growth.

  • News Sentiment

    Aurora Cannabis has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Aurora Cannabis this week, compared to 1 article on an average week.
  • Search Interest

    Only 4 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days.
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACB Stock News Headlines

The oil crisis is spreading faster than you think
Tanker traffic through Hormuz has plunged from 110-130 daily transits to near zero, while 17% of Qatar's LNG capacity remains offline after missile strikes. Goldman Sachs named the UK the developed economy most exposed to a jet-fuel crunch, citing critically low reserves and a gutted refining base. Dow Chemical has already doubled polyethylene prices overnight. Garrett Goggin, CFA, CMT, points to four gold miners positioned for what comes next.tc pixel
See More Headlines

ACB Stock Analysis - Frequently Asked Questions

Aurora Cannabis' stock was trading at C$5.77 on January 1st, 2026. Since then, ACB stock has decreased by 12.8% and is now trading at C$5.03.

Aurora Cannabis Inc. (TSE:ACB) issued its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.07) EPS for the quarter. The firm earned $67.55 million during the quarter. Aurora Cannabis had a negative trailing twelve-month return on equity of 5.21% and a negative net margin of 9.53%.

Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA), Organigram (OGI) and Aurora Cannabis (ACBFF).

Company Calendar

Last Earnings
8/05/2026
Today
8/11/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
TSE:ACB
CIK
N/A
Fax
N/A
Employees
1,073
Year Founded
N/A

Price Target and Rating

High Price Target
C$8.50
Low Price Target
C$5.00
Potential Upside/Downside
+42.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
C($1.94)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$44.16 million
Net Margins
-9.53%
Pretax Margin
N/A
Return on Equity
-5.21%
Return on Assets
-1.87%

Debt

Debt-to-Equity Ratio
4.30
Current Ratio
5.36
Quick Ratio
2.48

Sales & Book Value

Annual Sales
C$314.07 million
Price / Sales
0.99
Cash Flow
C$4.04 per share
Price / Cash Flow
1.25
Book Value
C$8.55 per share
Price / Book
0.59

Miscellaneous

Outstanding Shares
61,942,000
Free Float
N/A
Market Cap
C$311.57 million
Optionable
Not Optionable
Beta
0.25
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (TSE:ACB) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners